Women who are diagnosed with ductal carcinoma in situ (DCIS) outside the NHS breast screening programme are around four times as likely to develop invasive breast cancer and to die from breast cancer ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced detailed clinical utility, performance and safety results from its ...

An England-wide case-control study led by Queen Mary University of London has shown that, despite major improvements in diagnostic techniques and treatments, mammography screening continues to play an ...

Women who are diagnosed with ductal carcinoma in situ (DCIS) outside the NHS breast screening program are around four times as likely to develop invasive breast cancer and to die from breast cancer ...